Framework for estimating the financial contribution of a benign foregut practice: What general thoracic surgeons need to know

Objective: The study objective was to estimate payor-specific reimbursements for foregut surgery and determine the relative contribution compared with pulmonary procedures. Methods: Medical records of patients undergoing foregut surgery, identified by Diagnosis-Related Group codes 326, 327, and 328, by thoracic surgeons from January 2018 to December 2019 were reviewed. Esophagectomies and primary neoplasm diagnoses were excluded. Volume of surgeries, preoperative and postoperative studies, and clinic visits were measured. Reimbursements were estimated using Current Procedural Terminology and Diagnosis-Related Group Medicare data, cost-to-charge ratios, and Private:Medicare/Medicaid:Medicare payment ratios. Average payments for foregut and equivalent complexity pulmonary Diagnosis-Related Group codes were compared to calculate relative contribution. Results: A total of 72 patients met inclusion criteria and underwent 73 operations (hiatal hernia in 62 [85%] and esophageal diverticulectomy or myotomy in 11 [15%]), 538 studies, and 284 clinic visits. This volume equated to $12.7M in charges and $2.0M in Medicare reimbursement. Adjusting for a 59% Private, 32% Medicare, and 9% Medicaid payor mix, total reimbursement was $3.7M. Average reimbursement per surgery was $60k for Private, $35k for Medicare, and $28k for Medicaid. Total costs and operating income were $3.2M and $503k (ie, 14% operating margin), respectively. Compared with pulmonary procedures, foregut averaged greater reimbursement for the highest complexity cohort but less reimbursement for lower complexity cases (P ≤ .02). Conclusions: This framework can estimate payor-specific reimbursements, costs, and operating margins for both foregut and pulmonary surgeries. There are no financial disadvantages to having a diverse practice model. Balance of payor mix, case complexity, and a focus on reduced perioperative cost and increased care efficiency can improve margins and throughput.

Authors

Publication Details

Journal
JTCVS Open
Published
2025-11-17
DOI
https://doi.org/10.1016/j.xjon.2025.10.031
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Framework for estimating the financial contribution of a benign foregut practice: What general thoracic surgeons need to know

Takashi Harano, Anthony W. Kim, Arman Ashrafi, Brooks V. Udelsman et al.
JTCVS Open
Lung Cancer Diagnosis and Treatment
article

Framework for estimating the financial contribution of a benign foregut practice: What general thoracic surgeons need to know

Takashi Harano, Anthony W. Kim, Arman Ashrafi, Brooks V. Udelsman, Graeme Rosenberg, Scott M. Atay, Sean C. Wightman
article en

Abstract

Objective: The study objective was to estimate payor-specific reimbursements for foregut surgery and determine the relative contribution compared with pulmonary procedures. Methods: Medical records of patients undergoing foregut surgery, identified by Diagnosis-Related Group codes 326, 327, and 328, by thoracic surgeons from January 2018 to December 2019 were reviewed. Esophagectomies and primary neoplasm diagnoses were excluded. Volume of surgeries, preoperative and postoperative studies, and clinic visits were measured. Reimbursements were estimated using Current Procedural Terminology and Diagnosis-Related Group Medicare data, cost-to-charge ratios, and Private:Medicare/Medicaid:Medicare payment ratios. Average payments for foregut and equivalent complexity pulmonary Diagnosis-Related Group codes were compared to calculate relative contribution. Results: A total of 72 patients met inclusion criteria and underwent 73 operations (hiatal hernia in 62 [85%] and esophageal diverticulectomy or myotomy in 11 [15%]), 538 studies, and 284 clinic visits. This volume equated to $12.7M in charges and $2.0M in Medicare reimbursement. Adjusting for a 59% Private, 32% Medicare, and 9% Medicaid payor mix, total reimbursement was $3.7M. Average reimbursement per surgery was $60k for Private, $35k for Medicare, and $28k for Medicaid. Total costs and operating income were $3.2M and $503k (ie, 14% operating margin), respectively. Compared with pulmonary procedures, foregut averaged greater reimbursement for the highest complexity cohort but less reimbursement for lower complexity cases (P ≤ .02). Conclusions: This framework can estimate payor-specific reimbursements, costs, and operating margins for both foregut and pulmonary surgeries. There are no financial disadvantages to having a diverse practice model. Balance of payor mix, case complexity, and a focus on reduced perioperative cost and increased care efficiency can improve margins and throughput.

JTCVS OpenVol. 29
Openalex Percentile: Top 50%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.